Please use this identifier to cite or link to this item:
|Title:||UK national survey of current practice and experience of intravitreal triamcinolone acetonide.|
|Citation:||EYE (LOND), 2009, 23 (5), pp. 1164-1167|
|Abstract:||In recent years, intravitreal triamcinolone acetonide (IVTA) injections have become widely used in the treatment of macular oedema. IVTA can cause elevation of intraocular pressure (IOP), which can be sight threatening. We carried out a nationwide study, which aimed to (i) assess the current usage of IVTA, (ii) estimate the incidence of 'severe' IOP rise following IVTA, in routine practice.|
|Appears in Collections:||Published Articles, Dept. of Health Sciences|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.